Literature DB >> 30364215

Association of LOXL1 gene common sequence variants in Jordanian patients with exfoliation syndrome and exfoliative glaucoma.

Wisam Shihadeh1,2, Omar Khabour3,4, Mohammed Bilal Khalil5, Alaa Al-Dabbagh1, Mustafa Al-Hashimi1.   

Abstract

AIM: To investigate the association between single nucleotide polymorphisms (SNPs) in the LOXL1 gene with exfoliation syndrome/glaucoma (XFS/XFG) among Jordanians.
METHODS: Sixty-one patients with XFS/XFG and 59 healthy control individuals were recruited in the study. Patients were diagnosed with XFS/XFG using standard clinical examination techniques. The exonic rs1048661 SNP and the intronic rs2165241 SNP in LOXL1 gene were genotyped using sequencing technique. Allele and genotype frequencies were compared between cases and controls using Chi-square analysis.
RESULTS: The G allele of the rs1048661 SNP and the T allele of the rs2165241 SNP were common in the sample with frequencies of 86.4% and 81.4%, respectively. In addition, there were no significant differences in the genotypic and allelic distributions between patients and controls for rs1048661 SNP (P=0.770, OR=1.21, 95%CI: 0.56-2.60) and for rs2165241 SNP (P=0.605, OR=1.12, 95%CI: 0.59-2.09). In addition, no significant associations were found between haplotypes of the examined SNPs and XFS/XFG in the sample (P>0.05).
CONCLUSION: Variations in LOXL1 gene may not be associated with XFS/XFG in the Jordanian population. More studies are required to confirm the current findings.

Entities:  

Keywords:  Jordan; LOXL1; exfoliation syndrome; glaucoma; polymorphism

Year:  2018        PMID: 30364215      PMCID: PMC6192963          DOI: 10.18240/ijo.2018.10.02

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  39 in total

1.  Physical linkage of the lysyl oxidase-like (LOXL1) gene to the PML gene on human chromosome 15q22.

Authors:  A Goy; F Gilles; Y Remache; A D Zelenetz
Journal:  Cytogenet Cell Genet       Date:  2000

2.  The Pro-regions of lysyl oxidase and lysyl oxidase-like 1 are required for deposition onto elastic fibers.

Authors:  Laetitia Thomassin; Claudio C Werneck; Thomas J Broekelmann; Claudine Gleyzal; Ian K Hornstra; Robert P Mecham; Pascal Sommer
Journal:  J Biol Chem       Date:  2005-10-26       Impact factor: 5.157

Review 3.  Expression and regulation of LOXL1 and elastin-related genes in eyes with exfoliation syndrome.

Authors:  Matthias Zenkel; Ursula Schlötzer-Schrehardt
Journal:  J Glaucoma       Date:  2014 Oct-Nov       Impact factor: 2.503

Review 4.  Lysyl oxidase: an oxidative enzyme and effector of cell function.

Authors:  H A Lucero; H M Kagan
Journal:  Cell Mol Life Sci       Date:  2006-10       Impact factor: 9.261

5.  Exfoliation syndrome: assembling the puzzle pieces.

Authors:  Louis R Pasquale; Terete Borrás; John H Fingert; Janey L Wiggs; Robert Ritch
Journal:  Acta Ophthalmol       Date:  2015-12-09       Impact factor: 3.761

Review 6.  Systemic Associations of Exfoliation Syndrome.

Authors:  Robert Ritch
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2016 Jan-Feb

7.  Analysis of LOXL1 polymorphisms in a Saudi Arabian population with pseudoexfoliation glaucoma.

Authors:  Khaled K Abu-Amero; Essam A Osman; Ahmed S Dewedar; Silke Schmidt; R Rand Allingham; Saleh A Al-Obeidan
Journal:  Mol Vis       Date:  2010-12-16       Impact factor: 2.367

8.  Association of lysyl oxidase-like 1 gene polymorphisms with exfoliation syndrome in Koreans.

Authors:  Min Sagong; Byoung Young Gu; Soon Cheol Cha
Journal:  Mol Vis       Date:  2011-10-28       Impact factor: 2.367

9.  Evaluation of LOXL1 polymorphisms in eyes with exfoliation glaucoma in Japanese.

Authors:  Nobuo Fuse; Akiko Miyazawa; Toru Nakazawa; Mingge Mengkegale; Takaaki Otomo; Kohji Nishida
Journal:  Mol Vis       Date:  2008-07-21       Impact factor: 2.367

10.  Lysyl oxidase-like protein 1 (LOXL1) gene polymorphisms and exfoliation glaucoma in a Central European population.

Authors:  Georg Mossböck; Wilfried Renner; Christoph Faschinger; Otto Schmut; Andreas Wedrich; Martin Weger
Journal:  Mol Vis       Date:  2008-05-09       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.